After dedicating five years to advocating for individuals with multiple sclerosis (MS), Christina Applegate has disclosed that medical professionals now believe she was initially misdiagnosed.
Expressing her feelings about the news, she stated, “To me, it feels like I’m starting over from the beginning.” Applegate shared her revelation during a two-part episode of the podcast MeSsy, which she co-hosts with Jamie-Lynn Sigler, who also has MS. She took a hiatus from the show to process this new development.
During the podcast, Applegate emotionally shared that despite her doctor’s relief at confirming the absence of MS, she did not feel a sense of joy, only confusion. She expressed, “You don’t just get misdiagnosed and suddenly everything is fine. I haven’t improved… if anything, some of my symptoms have worsened.”
Dr. Mark Freedman, from The Ottawa Hospital’s multiple sclerosis research unit, likened MS to a situation where the protective covering of a wire wears off, leaving the inner copper exposed. This exposure can lead to inflammation attacking the nerve, causing permanent damage and loss of connection.
Applegate initially revealed her MS diagnosis via social media in August 2021 after experiencing symptoms like numbness and pain in her feet that progressed over time. Despite undergoing various tests, including spinal and brain MRIs, and a spinal tap, it was not until doctors discovered nearly 40 brain lesions that she received an official MS diagnosis.
However, a few years later, her treatment was paused to reevaluate her condition, leading to doubts about her initial diagnosis. After updated diagnostic criteria and advanced MRI technology were considered, it was determined that Applegate did not have MS. She expressed feeling lost without a definitive diagnosis to explain her ongoing symptoms.
Acknowledging her emotional journey, Applegate expressed regret for potentially misleading others and felt a loss of identity without the MS label. Despite the setback, her co-host Sigler reassured her that her advocacy work remained significant. Sigler optimistically hoped for a future where Applegate could resume activities like dancing.
Globally, over 3.1 million people live with MS, with Canada having a high prevalence, affecting roughly one in 400 Canadians, primarily women. Accurate diagnosis is challenging due to overlapping symptoms with other conditions. Misdiagnosis rates vary but can lead to inappropriate treatments with potential risks for patients.
In conclusion, while Applegate’s MS journey took an unexpected turn, her dedication to raising awareness about the disease remains impactful, offering hope for others navigating similar challenges.